November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Cihangir Akyol: Adjuvant chemotherapy duration for stage III colon cancer patients with tumor deposits
Nov 4, 2024, 12:17

Cihangir Akyol: Adjuvant chemotherapy duration for stage III colon cancer patients with tumor deposits

Cihangir AkyolProfessor of Surgery at Ankara University, shared his recent article on X:

“Thrilled to share our latest publication in the Journal of Gastrointestinal Cancer!

This study reveals game-changing insights on adjuvant chemotherapy duration for stage III colon cancer patients with tumor deposits (pT1-3 / N1c / without LN involvement).

Our findings underscore the powerful impact of a 6-month regimen on improving survival outcomes, marking a step forward in personalized cancer care.”

Adjuvant Chemotherapy Duration and Disease-Free Survival in Low-Risk Stage III Colon Cancer with N1a-b and N1c Disease: Insights from a Single-Center Retrospective Analysis

Authors: Beliz Bahar Karaoğlan, İremsu Öztürk, Cihangir Akyol, Berna Savaş, Güngör Utkan

Adjuvant chemotherapy

Immunotherapy for Colon Cancer: Types, Success Rate, Side Effects & More

Dr. Cihangir Akyol is a Professor of Surgery at Ankara University Faculty of Medicine, Ibni Sina Hospital. He holds an international fellowship with the American Society of Colon and Rectal Surgeons and is a member of the European Society of Coloproctology (ESCP). Dr. Akyol serves as a reviewer for the Balkan Medical Journal and the Turkish Journal of Gastroenterology.